Dorsey Wright & Associates Zynerba Pharmaceuticals, Inc. Transaction History
Dorsey Wright & Associates
- $378 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding ZYNE
# of Institutions
5Shares Held
787KCall Options Held
0Put Options Held
0-
ETF Managers Group, LLC Summit, NJ723KShares$00.01% of portfolio
-
Zeke Capital Advisors, LLC Berwyn, PA49.7KShares$00.0% of portfolio
-
National Asset Management, Inc. Boca Raton, FL12.7KShares$00.0% of portfolio
-
Ahrens Investment Partners LLC1.04KShares$00.0% of portfolio
-
Kistler Tiffany Companies, LLC Berwyn, PA100Shares$00.0% of portfolio
About Zynerba Pharmaceuticals, Inc.
- Ticker ZYNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,753,100
- Description
- Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...